Chardan Healthcare Acquisition Corp.
CHAC.WS
CHAC.WS was delisted on the 28th of October, 2019.
5 hedge funds and large institutions have $2.9M invested in Chardan Healthcare Acquisition Corp. in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFM
Boothbay Fund Management
New York
|
+$136K |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$106K |
| 3 |
6CM
683 Capital Management
New York
|
+$75.5K |
| 4 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$50.1K |
| 5 |
BCM
Basso Capital Management
Stamford,
Connecticut
|
+$25.2K |
Top Sellers
CHAC.WS Hedge Fund Activity: Q1 2019 in Review
5 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Chardan Healthcare Acquisition Corp. (CHAC.WS) for Q1 2019, worth a combined $2.9M.
Buyers outnumbered sellers: 5 funds opened new CHAC.WS positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Boothbay Fund Management, opening a new position worth an estimated $136K.
- 5 institutional investors held Chardan Healthcare Acquisition Corp. (CHAC.WS) as of Q1 2019, up from 0 in Q4 2018.
- Funds reported $2.9M of Chardan Healthcare Acquisition Corp. stock for Q1 2019.
- 5 funds opened new Chardan Healthcare Acquisition Corp. positions in Q1 2019 and 0 closed out, a net change of +5 holders.
- The largest Chardan Healthcare Acquisition Corp. buyer in Q1 2019 was Boothbay Fund Management, an estimated $136K added.
Based on aggregated 13F filings for Q1 2019.